Bourla was responding after the president’s call for transparency on COVID-19 vaccines.
Pfizer’s CEO on Sept. 3 said President Donald Trump should receive a Nobel Peace Prize for the operation that helped deliver COVID-19 vaccines within months of the start of the COVID-19 pandemic.
Albert Bourla said in a statement that Operation Warp Speed and the development of COVID-19 vaccines by Pfizer and Moderna “is a profound public health achievement” that was achieved under the leadership of Trump during the president’s first term.
“This American leadership also delivered a new platform that may drive significant innovation in cancer research,” Bourla said. “Such an accomplishment would typically be worthy of the Nobel Peace Prize, given its significant impact.”
Sen. Bill Cassidy (R-La.), a doctor who chairs the Senate Health Committee, also said on Wednesday that Trump deserves a Nobel Prize for Operation Warp Speed.
The Nobel Peace Prize is awarded to people who have achieved success in one of four areas: “arms control and disarmament, peace negotiation, democracy and human rights, and work aimed at creating a better organized and more peaceful world,” according to the prize’s website.
Bourla was responding after Trump recently said that “it is very important that the Drug Companies justify the success of their various Covid Drugs.” He said that Pfizer and others have shown him information “that is extraordinary, but they never seem to show those results to the public,” and urged the parties to make public the information.
Trump, who has repeatedly touted what he has described as the operation’s success, also wrote: “I hope Operation Warp Speed was as ‘brilliant’ as many say it was. If not, we all want to know about it, and why?”
“President Trump’s call for transparency is welcomed,” Bourla said.
He declined to release any new information. Instead, he pointed to a link on Pfizer’s website that contains studies and other data on COVID-19 vaccines.
Pfizer will add more information and studies by the end of September, according to Bourla. The official said that Pfizer will soon share data about its updated COVID-19 vaccine, which targets the LP.8.1 strain.
